Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.

Arabanian LS, Johansson P, Staffas A, Nilsson T, Rouhi A, Fogelstrand L, Palmqvist L.

Leuk Res. 2018 Dec;75:61-68. doi: 10.1016/j.leukres.2018.10.005. Epub 2018 Oct 13.

PMID:
30384975
2.

Identification of validated case definitions for medical conditions used in primary care electronic medical record databases: a systematic review.

McBrien KA, Souri S, Symonds NE, Rouhi A, Lethebe BC, Williamson TS, Garies S, Birtwhistle R, Quan H, Fabreau GE, Ronksley PE.

J Am Med Inform Assoc. 2018 Nov 1;25(11):1567-1578. doi: 10.1093/jamia/ocy094.

PMID:
30137498
3.

"Wounded Meningioma Syndrome": Postoperative Exacerbation of Brain Edema in Brain-Invasive Meningioma.

Saffarian A, Derakhshan N, Taghipour M, Eghbal K, Rouhi A.

World Neurosurg. 2018 Jul;115:483-484. doi: 10.1016/j.wneu.2018.03.106. No abstract available.

PMID:
29958375
4.

Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes.

Grasedieck S, Mulaw M, Sperb N, Wessinger K, Rouhi A, Bommer M, Bromberg JEC, Otto M, Tumani H, von Arnim CAF, Mertens D, Kuchenbauer F.

Neuropathol Appl Neurobiol. 2018 Apr 21. doi: 10.1111/nan.12491. [Epub ahead of print] No abstract available.

PMID:
29679382
5.

Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.

Bhayadia R, Krowiorz K, Haetscher N, Jammal R, Emmrich S, Obulkasim A, Fiedler J, Schwarzer A, Rouhi A, Heuser M, Wingert S, Bothur S, Döhner K, Mätzig T, Ng M, Reinhardt D, Döhner H, Zwaan CM, van den Heuvel Eibrink M, Heckl D, Fornerod M, Thum T, Humphries RK, Rieger MA, Kuchenbauer F, Klusmann JH.

J Clin Oncol. 2018 Apr 1;36(10):1007-1016. doi: 10.1200/JCO.2017.75.2204. Epub 2018 Feb 12.

PMID:
29432078
6.

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.

Schneider E, Staffas A, Röhner L, Malmberg ED, Ashouri A, Krowiorz K, Pochert N, Miller C, Wei SY, Arabanian L, Buske C, Döhner H, Bullinger L, Fogelstrand L, Heuser M, Döhner K, Xiang P, Ruschmann J, Petriv OI, Heravi-Moussavi A, Hansen CL, Hirst M, Humphries RK, Rouhi A, Palmqvist L, Kuchenbauer F.

Haematologica. 2018 Feb;103(2):246-255. doi: 10.3324/haematol.2017.177485. Epub 2017 Dec 7.

7.

Stk33 is required for spermatid differentiation and male fertility in mice.

Martins LR, Bung RK, Koch S, Richter K, Schwarzmüller L, Terhardt D, Kurtulmus B, Niehrs C, Rouhi A, Lohmann I, Pereira G, Fröhling S, Glimm H, Scholl C.

Dev Biol. 2018 Jan 1;433(1):84-93. doi: 10.1016/j.ydbio.2017.11.007. Epub 2017 Nov 16.

8.

A Systematic Review of Quality Measures for Inflammatory Arthritis.

Cooper M, Rouhi A, Barber CEH.

J Rheumatol. 2018 Feb;45(2):274-283. doi: 10.3899/jrheum.170157. Epub 2017 Nov 15.

9.

STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway.

Liu Y, Steinestel K, Rouhi A, Armacki M, Diepold K, Chiosis G, Simmet T, Seufferlein T, Azoitei N.

Oncotarget. 2017 Aug 24;8(44):77474-77488. doi: 10.18632/oncotarget.20535. eCollection 2017 Sep 29.

10.

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia.

Hirsch S, Blätte TJ, Grasedieck S, Cocciardi S, Rouhi A, Jongen-Lavrencic M, Paschka P, Krönke J, Gaidzik VI, Döhner H, Schlenk RF, Kuchenbauer F, Döhner K, Dolnik A, Bullinger L.

Haematologica. 2017 Dec;102(12):2039-2047. doi: 10.3324/haematol.2017.172866. Epub 2017 Sep 29.

11.

NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib.

Wolf C, Garding A, Filarsky K, Bahlo J, Robrecht S, Becker N, Zucknick M, Rouhi A, Weigel A, Claus R, Weichenhan D, Eichhorst B, Fischer K, Hallek M, Kuchenbauer F, Plass C, Döhner H, Stilgenbauer S, Lichter P, Mertens D.

Int J Cancer. 2018 Jan 15;142(2):322-333. doi: 10.1002/ijc.31057. Epub 2017 Oct 9.

12.

Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional Therapy.

Bohl SR, Kuchenbauer F, von Harsdorf S, Kloevekorn N, Schönsteiner SS, Rouhi A, Schwarzwälder P, Döhner H, Bunjes D, Bommer M.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2172-2177. doi: 10.1016/j.bbmt.2017.08.019. Epub 2017 Aug 30.

13.

Prevalence and risk factors for liver fibrosis detected by transient elastography or shear wave elastography in inflammatory arthritis: a systematic review.

Rouhi A, Hazlewood G, Shaheen AA, Swain MG, Barber CEH.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1029-1036. Epub 2017 Jun 5. Review.

PMID:
28598786
14.

FOXtrotting with PUMILIOs.

Rouhi A, Kuchenbauer F.

Blood. 2017 May 4;129(18):2459-2460. doi: 10.1182/blood-2017-03-771469. No abstract available.

15.

Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.

Mohr S, Doebele C, Comoglio F, Berg T, Beck J, Bohnenberger H, Alexe G, Corso J, Ströbel P, Wachter A, Beissbarth T, Schnütgen F, Cremer A, Haetscher N, Göllner S, Rouhi A, Palmqvist L, Rieger MA, Schroeder T, Bönig H, Müller-Tidow C, Kuchenbauer F, Schütz E, Green AR, Urlaub H, Stegmaier K, Humphries RK, Serve H, Oellerich T.

Cancer Cell. 2017 Apr 10;31(4):549-562.e11. doi: 10.1016/j.ccell.2017.03.001.

16.

Identification of validated case definitions for chronic disease using electronic medical records: a systematic review protocol.

Souri S, Symonds NE, Rouhi A, Lethebe BC, Garies S, Ronksley PE, Williamson TS, Fabreau GE, Birtwhistle R, Quan H, McBrien KA.

Syst Rev. 2017 Feb 23;6(1):38. doi: 10.1186/s13643-017-0431-9.

17.

MicroRNA-155 promotes G-CSF-induced mobilization of murine hematopoietic stem and progenitor cells via propagation of CXCL12 signaling.

Itkin T, Kumari A, Schneider E, Gur-Cohen S, Ludwig C, Brooks R, Kollet O, Golan K, Khatib-Massalha E, Russo CM, Chisholm JD, Rouhi A, Geiger H, Hornstein E, Kerr WG, Kuchenbauer F, Lapidot T.

Leukemia. 2017 May;31(5):1247-1250. doi: 10.1038/leu.2017.50. Epub 2017 Feb 8. No abstract available.

PMID:
28174416
18.

Effects of Phthalates on the Biology of the Mussel Mytilus Galloprovincialis (from the Atlantic Coast of El Jadida, Morocco).

Sif J, Khalil A, Abouinan H, Rouhi A, Mokhliss K.

J Xenobiot. 2016 Dec 31;6(2):6589. doi: 10.4081/xeno.2016.6589. eCollection 2016 Dec 31. No abstract available.

19.
20.

Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells.

Rouhi A, Miller C, Grasedieck S, Reinhart S, Stolze B, Döhner H, Kuchenbauer F, Bullinger L, Fröhling S, Scholl C.

Oncotarget. 2017 Jan 31;8(5):7678-7690. doi: 10.18632/oncotarget.13841.

21.

MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.

Krowiorz K, Ruschmann J, Lai C, Ngom M, Maetzig T, Martins V, Scheffold A, Schneider E, Pochert N, Miller C, Palmqvist L, Staffas A, Mulaw M, Bohl SR, Buske C, Heuser M, Kraus J, O'Neill K, Hansen CL, Petriv OI, Kestler H, Döhner H, Bullinger L, Döhner K, Humphries RK, Rouhi A, Kuchenbauer F.

Blood Cancer J. 2016 Dec 9;6(12):e508. doi: 10.1038/bcj.2016.110. No abstract available.

22.

MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.

Schneider E, Staffas A, Röhner L, Krowiorz K, Heuser M, Döhner K, Bullinger L, Döhner H, Fogelstrand L, Rouhi A, Kuchenbauer F, Palmqvist L.

Exp Hematol. 2016 Dec;44(12):1166-1171. doi: 10.1016/j.exphem.2016.08.012. Epub 2016 Sep 13.

PMID:
27619068
23.

PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.

Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, Simmet T, Seufferlein T.

Mol Cancer. 2016 Jan 6;15:3. doi: 10.1186/s12943-015-0490-2.

24.

MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.

Gentner B, Pochert N, Rouhi A, Boccalatte F, Plati T, Berg T, Sun SM, Mah SM, Mirkovic-Hösle M, Ruschmann J, Muranyi A, Leierseder S, Argiropoulos B, Starczynowski DT, Karsan A, Heuser M, Hogge D, Camargo FD, Engelhardt S, Döhner H, Buske C, Jongen-Lavrencic M, Naldini L, Humphries RK, Kuchenbauer F.

Exp Hematol. 2015 Oct;43(10):858-868.e7. doi: 10.1016/j.exphem.2015.05.018. Epub 2015 Jul 8.

25.

Optimal Design of Air Quality Monitoring Network and its Application in an Oil Refinery Plant: An Approach to Keep Health Status of Workers.

ZoroufchiBenis K, Fatehifar E, Ahmadi J, Rouhi A.

Health Promot Perspect. 2016 Jan 30;5(4):269-79. doi: 10.15171/hpp.2015.032. eCollection 2015.

26.

HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization.

Azoitei N, Diepold K, Brunner C, Rouhi A, Genze F, Becher A, Kestler H, van Lint J, Chiosis G, Koren J 3rd, Fröhling S, Scholl C, Seufferlein T.

Cancer Res. 2014 Dec 1;74(23):7125-36. doi: 10.1158/0008-5472.CAN-14-1017. Epub 2014 Oct 8.

27.

Deregulation of the CDX2-KLF4 axis in acute myeloid leukemia and colon cancer.

Rouhi A, Fröhling S.

Oncotarget. 2013 Feb;4(2):174-5. No abstract available.

28.

A report of a probable case of familial Guillain Barre syndrome.

Barzegar M, Rouhi AH, Farhoudi M, Sardashti S.

Ann Indian Acad Neurol. 2012 Oct;15(4):299-302. doi: 10.4103/0972-2327.104341.

29.

Impact of serum storage conditions on microRNA stability.

Grasedieck S, Schöler N, Bommer M, Niess JH, Tumani H, Rouhi A, Bloehdorn J, Liebisch P, Mertens D, Döhner H, Buske C, Langer C, Kuchenbauer F.

Leukemia. 2012 Nov;26(11):2414-6. doi: 10.1038/leu.2012.106. Epub 2012 Apr 16. No abstract available.

PMID:
22504138
30.

Stem cells and beyond: report on the 40th Annual Scientific Meeting of the International Society of Experimental Hematology.

Rouhi A, Buske C.

Expert Rev Hematol. 2011 Dec;4(6):591-2. doi: 10.1586/EHM.11.65.

PMID:
22077522
31.

CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.

Mulaw MA, Krause A, Deshpande AJ, Krause LF, Rouhi A, La Starza R, Borkhardt A, Buske C, Mecucci C, Ludwig WD, Lottaz C, Bohlander SK.

Leukemia. 2012 May;26(5):1012-9. doi: 10.1038/leu.2011.307. Epub 2011 Nov 8. Erratum in: Leukemia. 2012 Dec;26(12):2570. Krause, A J [corrected to Krause, A].

PMID:
22064352
32.

The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.

Deshpande AJ, Rouhi A, Lin Y, Stadler C, Greif PA, Arseni N, Opatz S, Quintanilla-Fend L, Holzmann K, Hiddemann W, Döhner K, Döhner H, Xu G, Armstrong SA, Bohlander SK, Buske C.

Leukemia. 2011 Nov;25(11):1718-27. doi: 10.1038/leu.2011.153. Epub 2011 Jun 17.

PMID:
21681188
33.

Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.

Kuchenbauer F, Mah SM, Heuser M, McPherson A, Rüschmann J, Rouhi A, Berg T, Bullinger L, Argiropoulos B, Morin RD, Lai D, Starczynowski DT, Karsan A, Eaves CJ, Watahiki A, Wang Y, Aparicio SA, Ganser A, Krauter J, Döhner H, Döhner K, Marra MA, Camargo FD, Palmqvist L, Buske C, Humphries RK.

Blood. 2011 Sep 22;118(12):3350-8. doi: 10.1182/blood-2010-10-312454. Epub 2011 May 31.

34.

Emergency department patient satisfaction survey in Imam Reza Hospital, Tabriz, Iran.

Soleimanpour H, Gholipouri C, Salarilak S, Raoufi P, Vahidi RG, Rouhi AJ, Ghafouri RR, Soleimanpour M.

Int J Emerg Med. 2011 Jan 27;4:2. doi: 10.1186/1865-1380-1-2.

35.

MicroRNA-146a disrupts hematopoietic differentiation and survival.

Starczynowski DT, Kuchenbauer F, Wegrzyn J, Rouhi A, Petriv O, Hansen CL, Humphries RK, Karsan A.

Exp Hematol. 2011 Feb;39(2):167-178.e4. doi: 10.1016/j.exphem.2010.09.011. Epub 2010 Oct 7.

PMID:
20933052
36.

Meis1 disrupts the genomic imprint of Dlk1 in a NUP98-HOXD13 leukemia model.

Argiropoulos B, Palmqvist L, Imren S, Miller M, Rouhi A, Mager DL, Humphries RK.

Leukemia. 2010 Oct;24(10):1788-91. doi: 10.1038/leu.2010.161. Epub 2010 Aug 26. No abstract available.

PMID:
20739957
37.

Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.

Xiang P, Lo C, Argiropoulos B, Lai CB, Rouhi A, Imren S, Jiang X, Mager D, Humphries RK.

Exp Hematol. 2010 Sep;38(9):798-8, 808.e1-2. doi: 10.1016/j.exphem.2010.06.006. Epub 2010 Jun 23.

38.

Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia.

Rogers SL, Zhao Y, Jiang X, Eaves CJ, Mager DL, Rouhi A.

Mol Cancer. 2010 Feb 22;9:41. doi: 10.1186/1476-4598-9-41.

39.

Variable DNA methylation of transposable elements: the case study of mouse Early Transposons.

Reiss D, Zhang Y, Rouhi A, Reuter M, Mager DL.

Epigenetics. 2010 Jan 1;5(1):68-79. Epub 2010 Jan 13.

PMID:
20083901
40.

Evidence for high bi-allelic expression of activating Ly49 receptors.

Rouhi A, Lai CB, Cheng TP, Takei F, Yokoyama WM, Mager DL.

Nucleic Acids Res. 2009 Sep;37(16):5331-42. doi: 10.1093/nar/gkp592. Epub 2009 Jul 15.

41.

MiRNAs, epigenetics, and cancer.

Rouhi A, Mager DL, Humphries RK, Kuchenbauer F.

Mamm Genome. 2008 Aug;19(7-8):517-25. doi: 10.1007/s00335-008-9133-x. Epub 2008 Aug 8. Review.

PMID:
18688563
43.

Plasticity of Ly49g expression is due to epigenetics.

Rouhi A, Brooks CG, Takei F, Mager DL.

Mol Immunol. 2007 Feb;44(5):821-6. Epub 2006 Jun 5.

PMID:
16750269
44.

Evidence for epigenetic maintenance of Ly49a monoallelic gene expression.

Rouhi A, Gagnier L, Takei F, Mager DL.

J Immunol. 2006 Mar 1;176(5):2991-9.

45.

Relationship between endoscopic nodular gastritis and Helicobacter pylori infection in children.

Rafeey M, Jafari Rouhi AH, Gassemi BA, Rouhi AJ.

Indian J Gastroenterol. 2004 Jul-Aug;23(4):138-9.

PMID:
15333969
46.

The Opitz syndrome gene Mid1 is transcribed from a human endogenous retroviral promoter.

Landry JR, Rouhi A, Medstrand P, Mager DL.

Mol Biol Evol. 2002 Nov;19(11):1934-42.

PMID:
12411602
47.

Vortex filament stability and boundary layer dynamics.

Abarbanel HD, Lisi AG, Rouhi A, Wright JA.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1994 Aug;50(2):1206-1218. No abstract available.

PMID:
9962081
48.

Symmetric truncations of the shallow-water equations.

Rouhi A, Abarbanel HD.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1993 Nov;48(5):3643-3655. No abstract available.

PMID:
9961021
49.

Hamiltonian formulation for the motion of vortices in the presence of a free surface for ideal flow.

Rouhi A, Wright J.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1993 Sep;48(3):1850-1865. No abstract available.

PMID:
9960796
50.

[Prevention and therapy of supraventricular paroxysmal tachycardia in ambulatory patients. Results of a multicentric study using disopyramide].

Rouhi A, Penth B, Adams HJ.

Ther Ggw. 1979 Jun;118(6):957-69. German. No abstract available.

PMID:
462395

Supplemental Content

Support Center